Selank + Semax: Cognitive Enhancement
A complementary nootropic stack from Russian peptide research pairing Selank's anxiolytic and stress-modulating properties with Semax's BDNF-upregulating and cognitive-enhancing effects. Selank reduces anxiety and stabilises mood via modulation of the enkephalin system and GABAergic tone, while Semax enhances focus, memory consolidation, and neuroprotection through BDNF and ACTH-related pathways. Together they aim to eliminate cognitive friction while amplifying mental output.
Safety Notes
Both are Russian-developed synthetic peptides with a history of clinical use in Russia and Eastern Europe; neither is FDA-approved in the United States. Independent Western replication of their safety and efficacy data is limited. Both are typically administered intranasally. Potential interactions with psychiatric medications, anxiolytics, or other nootropics are not characterised; use alongside such agents warrants medical supervision.
Peptides in This Stack
- 1SemaxCognitive
Upregulates BDNF synthesis and mimics ACTH-derived peptide activity to enhance focus, working memory, and neuroprotection — the primary cognitive performance driver of this stack.
- 2SelankCognitive
Modulates the enkephalin system and GABAergic tone to reduce anxiety and psychological stress without sedation, creating the calm mental baseline on which Semax's cognitive enhancement can operate most effectively.
Research References
Emerging
- Semax, an Analog of ACTH(4-10) with Cognitive Effects, Regulates BDNF and tPA ExpressionAnn N Y Acad Sci 2006 · PMID 17148770
Preliminary
- Effect of Selank on anxiety and depressionEksp Klin Farmakol 2010Russian-language journal, single institute, limited independent Western replication
PeptideBase provides educational research tools and provider discovery. It does not provide medical advice, diagnosis, treatment, prescribing guidance, or dosing instructions. Consult a qualified healthcare professional before making health decisions.